Resources and tools for your practice
Dosing Guide
Financial Flashcard
ALTUVIIIO billing and coding information
The following ICD-10-CM code may be used to identify patient medical conditions typically associated with hemophilia A.
The following miscellenous HCPCS codes can be used for ALTUVIIIO. The prescriber is advised to verify with the payer or Medicare fiscal intermediary to determine the correct code(s).
Code type | Code number | Description |
ICD-10-CM | D66 | Hereditary Factor VIII deficiency |
HCPCS | J7214 | Injection, Factor VIII/von Willebrand factor complex, recombinant (ALTUVIIIO) per Factor VIII IU |
C9399 | Unclassified drugs or biologics (Medicare hospital outpatient setting) |
ALTUVIIIO National Drug Codes (NDCs)
NDCs are unique 3-segment numbers that serve as universal product identifiers for human drugs in the US.1 The bolded "0" in the NDC column below represents the 11th digit required for filing claims. Payer requirements for NDC use and format may vary. Please contact each payer for specific coding policies.
Strength2 | NDC2 |
250 IU | 71104-0978-01 |
500 IU | 71104-0979-01 |
1000 IU | 71104-0981-01 |
2000 IU | 71104-0982-01 |
3000 IU | 71104-0983-01 |
4000 IU | 71104-0984-01 |
This billing and coding information is provided for informational purposes only and does not constitute legal or reimbursement advice. It is not intended to substitute for the physician’s independent diagnosis or treatment of each patient. The information contained herein is gathered from various resources and is subject to change. Providers are solely responsible for the accuracy of all coding and claims submitted for reimbursement to any third-party payer.
Free laboratory tests for ALTUVIIIO
Sanofi has contracted with LabCorp (Esoterix) to provide a central lab to perform standardized one-stage clotting assays with a national network of local laboratories for specimen collection at no extra cost for the patient or healthcare provider.
Learn more information about monitoring with LabCorp.
Simple dosing with ALTUVIIIO
Infused the same way as Factor VIII replacement therapies but taken less frequently.
Resources for your patients
ALTUVIIIO offers a range of helpful resources and access programs for your patients.
Indication
HCPCS=Healthcare Common Procedure Coding System; IU=international unit.
Reference: 1. US Food and Drug Administration. National Drug Code Directory. Updated July 22, 2022. Accessed September 8, 2023. https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory 2. ALTUVIIIO Prescribing Information. Bioverativ Therapeutics Inc. Waltham, MA.